Publications by authors named "E W Isa"

Article Synopsis
  • * It involved 496 healthcare professionals from three hospitals, analyzing hair cortisol levels as a chronic stress biomarker and finding significant associations between high cortisol levels, workload, age, and emotional exhaustion.
  • * The research concludes that burnout in 11% of participants correlates with increased stress and lower social support, emphasizing the need for targeted interventions to enhance healthcare workers' well-being.
View Article and Find Full Text PDF

A selective composite membrane for vanadium redox flow battery (VRFB) was successfully prepared by layer-by-layer (LbL) technique using a perfluorosulfonic sulfonic acid or Nafion 117 (N117). The composite membrane referred as N117-(PEI/GO), was obtained by depositing alternating layers of positively charged polyethylenimine (PEI) and negatively charged graphene oxide (GO) as polyelectrolytes. The physicochemical properties and performance of the pristine and composite membranes were investigated.

View Article and Find Full Text PDF

Purpose: Limiting cardiac radiation dose is important for minimizing long-term cardiac toxicity in patients with left-sided early-stage breast cancer.

Methods And Materials: Prospectively collected dosimetric data were analyzed for patients undergoing moderately hypofractionated radiation therapy to the left breast within the Michigan Radiation Oncology Quality Consortium from 2016 to 2022. The mean heart dose (MHD) goal was progressively tightened from ≤2 Gy in 2016 to MHD ≤ 1.

View Article and Find Full Text PDF

The scarcity of water leads to research nowadays to focus on techniques for treating wastewater. Photocatalysis emerged as a technique of interest due to its nature of friendliness. It utilizes light and catalyst to degrade the pollutants.

View Article and Find Full Text PDF

Introduction To identify predictors of definitive treatment interruptions (DTI) of the neoadjuvant long-course radiotherapy (LCRT) in locally advanced rectal cancer (LARC), and to determine their impact on clinical outcomes. Methods Patients with stage II-III LARC treated between 2009-2018 were retrospectively analyzed (n=101, median FU 49.5 months).

View Article and Find Full Text PDF